GILEAD SCIENCES INC ($GILD)

4 tracked superinvestors hold GILEAD SCIENCES INC (GILD), worth $4.4B combined, led by Team. Smart money is trimming GILD as of the latest 13F filings.

Current price

$134.84

Drug Manufacturers - GeneralNASDAQUS

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment…

Market cap

$163.4B

P/E

16.15

Div yield

2.5%

Revenue YoY

2.4%

Analyst target

$162

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

4

tracked 13F / N-PORT funds

Combined value

$4.4B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

-2

1 buying · 3 selling

Smart money is net reducing GILD: 3 funds trimmed versus 1 adding.

The smart-money take on GILD

GILEAD SCIENCES INC (GILD) appears mainly in diversified and quant books here (4 funds, $4.4B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The largest position belongs to Team at 2.3% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 1 added and 3 trimmed, a net reduction.

Superinvestors holding GILD

InvestorMove% of their portfolioPosition value
3
Team

Dodge & Cox Stock

Trimmed2.3%$2.5B
3
Will Danoff

Fidelity Contrafund

Added1%$1.4B
2
ex-Jim Simons

Renaissance Technologies

Trimmed0.5%$300M
3
Joel Tillinghast

Fidelity Low-Priced Stock

Trimmed0.6%$138M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own GILD?

4 tracked funds hold GILEAD SCIENCES INC (GILD), the largest being Team (Dodge & Cox Stock) at 2.3% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling GILD?

In the most recent 13F quarter, 1 tracked fund added or opened GILD and 3 trimmed it.

How much GILD do tracked funds hold?

Combined disclosed long exposure to GILD across tracked superinvestors is $4.4B as of the Mar 2026 filings.

Stocks often held alongside GILD

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.